STOCK TITAN

TransDigm Group INC (TDG) SEC Filings, Feb 3-18, 2026

TDG NYSE

Welcome to our dedicated page for TransDigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TransDigm Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TransDigm Group's regulatory disclosures and financial reporting.

Rhea-AI Summary

TransDigm Group Co‑Chief Operating Officer Joel Reiss exercised stock options for 3,900 shares of common stock at an exercise price of $284.97 per share and received the underlying shares on February 17, 2026.

On the same day, he sold 3,900 TransDigm common shares in multiple open‑market transactions at prices generally between about $1,279 and $1,305 per share. After these trades, Reiss directly holds 3,600 shares of common stock and 31,400 stock options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TransDigm Group insider plans a Rule 144 share sale. A person identified as JOEL B REISS filed to sell 15,600 shares of TransDigm common stock through Morgan Stanley Smith Barney, with an aggregate market value of 20,072,052.00, on or about 02/17/2026 on the NYSE.

The shares were acquired the same day via an exercise of stock options for cash. The notice states there were 56,473,563 common shares outstanding. Over the prior three months, the filer’s 10b5-1 sales included 3,900 shares on 01/15/2026 for gross proceeds of 5,576,694.63 and 3,900 shares on 12/15/2025 for 5,033,033.46.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

TransDigm Group Incorporated reported that its subsidiary TransDigm Inc. has completed $2,000 million of new debt financing to support previously announced acquisitions. The financing includes $1,200 million of 6.125% senior subordinated notes due July 31, 2034 and $800 million of new tranche N term loans maturing February 13, 2033. The notes were issued at 100% of principal, pay 6.125% interest semi-annually starting July 31, 2026, and are guaranteed on a senior subordinated basis by TD Group and certain restricted subsidiaries. The term loans bear interest at Term SOFR plus a 2.50% margin and were fully drawn on February 13, 2026. TransDigm intends to use the net proceeds, along with cash on hand, to fund the aggregate purchase price of Stellant Systems, Inc., Jet Parts Engineering, Victor Sierra Aviation Holdings and related transaction fees and expenses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

TransDigm Group Incorporated priced an aggregate of $2,000 million of new debt to help fund previously announced acquisitions of Stellant Systems, Jet Parts Engineering and Victor Sierra Aviation Holdings and to pay related fees and expenses.

The company priced $1,200 million of 6.125% Senior Subordinated Notes due 2034, issued at 100% of principal by wholly owned subsidiary TransDigm Inc. and guaranteed by TransDigm Group and certain subsidiaries. Concurrently, TransDigm Inc. expects to incur up to $800 million of new tranche N term loans under a credit agreement amendment, with a maturity in February 2033.

The notes are being offered to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S, and are not registered under U.S. securities laws. The company also highlights customary forward-looking risks, including execution of the offerings, completion and integration of the acquisitions, leverage, macroeconomic conditions, supply chain, regulatory and geopolitical factors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

TransDigm Group president and CEO Michael Lisman bought 950 shares of TransDigm common stock on February 6, 2026 at $1,284.2608 per share, increasing his directly held stake to 3,259 shares. He also beneficially owns 1,954 shares indirectly through the Michael Lisman Declaration of Trust dated January 31, 2023.

A note clarifies that a Form 4 filed on November 14, 2025 mistakenly duplicated the 1,954 trust shares, and confirms that 1,954 is the correct number of shares held indirectly in the trust.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TransDigm Group Incorporated is planning, through its wholly owned subsidiary TransDigm Inc., to raise $2,000 million in new debt, subject to market and other conditions. The plan includes $1,000 million of new senior subordinated notes and $1,000 million of new term loans to be launched at the same time.

Net proceeds from this incremental debt, together with cash on hand, are intended to fund the aggregate purchase price of the previously announced acquisitions of Stellant Systems, Jet Parts Engineering and Victor Sierra Aviation Holdings, plus related fees and expenses. The notes will be privately offered under Rule 144A and Regulation S, guaranteed by TransDigm Group and certain subsidiaries, and not registered under the Securities Act.

Concurrently, TransDigm expects to amend its existing credit agreement via Amendment No. 20 to add up to $1,000 million of new tranche N term loans. Completion of both the notes offering and the credit agreement amendment remains subject to market and other conditions, and neither closing depends on the other.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

TransDigm Group’s Chief Financial Officer, Sarah Wynne, reported an option exercise and related share acquisition. On 02/05/2026, she exercised stock options for 1,494 shares of common stock at $559.78 per share. Following the transaction, she directly owned 4,894 shares of common stock and 3,506 stock options.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

TransDigm Group reported first-quarter fiscal 2026 net sales of $2,285 million, up from $2,006 million, and net income of $445 million. Earnings per share applicable to common stockholders were $6.62 versus $7.62 a year earlier, reflecting higher interest expense and dividend-equivalent payments.

Operating income rose to $1,042 million, but interest expense increased to $475 million as total debt reached about $30.0 billion. Cash from operations was strong at $832 million, funding $907 million of acquisitions including Simmonds and several bolt-on deals, plus $106 million of share repurchases.

TransDigm ended the quarter with $2,528 million of cash and $859 million of undrawn revolver capacity. Subsequent agreements to buy Jet Parts Engineering, Victor Sierra Aviation Holdings and Stellant Systems for a combined approximately $3.16 billion in cash would further expand its aerospace and defense aftermarket portfolio if completed.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.31%
Tags
quarterly report
-
Rhea-AI Summary

TransDigm Group director Kevin M. Stein, through Fortuna Trust dated June 1, 2018, reported a series of open-market sales of TransDigm common stock on February 2, 2026. The trust sold multiple blocks of shares at average prices ranging from $1,431.4599 to $1,440.4800 per share.

Individual transactions included sales such as 3,093 shares at an average price of $1,433.4578 and 1,497 shares at $1,436.4265. Following these sales, Fortuna Trust was reported as indirectly holding 8,158 TransDigm common shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.31%
Tags
insider
Rhea-AI Summary

TransDigm Group director-related trust reports option exercises and share sales. On February 2, 2026, Fortuna Trust dated June 1, 2018, an entity associated with director Kevin M. Stein, exercised stock options for 25,000 shares at $341.28 and 23,000 shares at $342.31.

The trust then executed a series of open‑market sales of TransDigm common stock at prices mainly around $1,404–$1,431. Following these transactions, the trust’s indirectly held TransDigm common stock position reported in this filing was 19,233 shares.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.31%
Tags
insider

FAQ

How many TransDigm Group (TDG) SEC filings are available on StockTitan?

StockTitan tracks 166 SEC filings for TransDigm Group (TDG), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TransDigm Group (TDG)?

The most recent SEC filing for TransDigm Group (TDG) was filed on February 18, 2026.